Metabolic fates of 2′-deoxy-5-[18F]fluorouridine in tumor-bearing mice and human plasma
International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology - Tập 18 - Trang 539-545 - 1991
Tài liệu tham khảo
Abe, 1983, Studies on 18F-labeled pyrimidines. Tumor uptakes of 18F-5-fluorouracil, 18F-5-fluorouridine, and 18F-5-fluorodeoxyuridine in animals, Eur. J. Nucl. Med., 8, 258, 10.1007/BF00522517
Abe, 1985, Cancer detection with 18F-5-fluorodeoxyuridine—a new cancer diagnostic agent reflecting the nucleic acid metabolism, Jpn. J. Nucl. Med., 22, 583
Chadwick, 1972, The physiological disposition of 5-fluorouracil in mice bearing solid L1210 lymphocytic leukemia, Cancer Res., 32, 1045
Chaudhuri N. K., Mukherjee K. L. and Heidelberger C. Studies on fluorinated pyrimidines. VII—The degradative pathway. Biochem. Pharmacol.1, 328–341.
Evelhoch, 1989, In vivo19F nuclear magnetic resonance spectroscopy: a potential monitor of 5-fluorouracil pharmacokinetics and metabolism, Invest. New Drugs, 7, 5, 10.1007/BF00178187
Griffiith, 1986, β-Amino acids: mammalian metabolism and utility as α-amino acid analogues, Ann. Rev. Biochem., 55, 855, 10.1146/annurev.bi.55.070186.004231
Heidelberger, 1983, Fluorinated pyramidines and their nucleosides, Adv. Enzymol., 54, 57
Hull, 1988, Metabolites of 5-fluorouracil in plasma and urine, as monitored by 19F nuclear magnetic resonance spectroscopy, for patients receiving chemotherapy with or without methotrexate pretreatment, Cancer Res., 48, 1680
Ido, 1982, Biochemical applications of radioactive fluorine, 142
Ishiwata, 1988, Comparison of l-[I-11C]methionine and l-methyl-[11C]methionine for measuring in vivo protein synthesis rates with PET, J. Nucl. Med., 29, 1419
Ishiwata, 1988, Metabolic studies with l-[I-11C]tyrosine for the investigation of a kinetic model to measure protein synthesis rates with PET, J. Nucl. Med., 29, 524
Ishiwata, 1987, Automated synthesis of 5-[18F]fluoro-2′-deoxyuridine, Appl. Radiat. Isot., 38, 467, 10.1016/0883-2889(87)90101-8
Ishiwata, 1985, Studies on 18F-labeled pyrimidines III. Biochemical investigation of 18F-labeled pyrimidines and comparison with 3H-deoxythymidine in tumor-bearing rats and mice, Eur. J. Nucl. Med., 10, 39, 10.1007/BF00261761
Ishiwata, 1984, Studies on 18F-labeled pyrimidines II. Metabolic investigation of 18F-5-fluorouracil, 18F-5-fluoro-2′-deoxyuridine and 18F-5-fluorouridine in rats, Eur. J. Nucl. Med., 9, 185
Kameyama, 1991, Clinical application of 18FUdR in glioma patients—PET study of nucleic acid metabolism, J. Neurol. Neurosurg. Psychiat.
Kameyama, 1989, Nucleic acid metabolism in gliomas studied with 18FdUrd and PET, J. Cereb. Bld Flow Metab., 9, S221
Keniry, 1986, Noninvasive spectroscopic analysis of fluoropyrimidine metabolism in cultured tumor cells, Cancer Res., 46, 1754
Kiyosawa, 1986, Orbital tumor diagnosis by positron emission tomography using 18F-fluorodeoxyuridine, Ophthal. Res., 18, 292, 10.1159/000265451
Malet-Martino, 1986, Evidence for the importance of 5′-deoxy-5-fluorouridine catabolism in humans from 19F nuclear magnetic resonance spectrometry, Cancer Res., 46, 2105
Martino, 1985, Release of fluoride ion from 5′-deoxy-5-fluorouridine, an antineoplastic fluoropyrimidine, in humans, Drug Metab. Dispos., 13, 116
McSheehy, 1989, Prediction of 5-fluorouracil cytotoxity towards the Walker carcinosarcoma using peak integrals of fluoronucleotides measured by MRS in vivo, Br. J. Cancer, 60, 303, 10.1038/bjc.1989.275
Mukherjee, 1963, Studies on fluorinated pyrimidines xvii. Tissue distribution of 5-fluorouracil-2-C14 and 5-fluoro-2′-deoxyuridine in cancer patients, Cancer Res., 23, 67
Oldendorf, 1971, Brain uptake of radiolabeled amino acids, amines and hexoses after arterial injection, Am. J. Physiol., 221, 1629, 10.1152/ajplegacy.1971.221.6.1629
Sommadossi, 1982, Rapid catabolism of 5-fluorouracil in freshly isolated rat hepatocytes as analyzed by high performance liquid chromatography, J. Biol. Chem., 257, 8171, 10.1016/S0021-9258(18)34313-8
Stevens, 1984, 5-Fluorouracil metabolism monitored in vivo by 19F NMR, Br. J. Cancer, 113, 10.1038/bjc.1984.146
Tsurumi, 1990, 18F-fluoro-2′-deoxyuridine as a tracer of nucleic acid metabolism in brain tumors, J. Neurosurg., 72, 110, 10.3171/jns.1990.72.1.0110
Washtien, 1979, Assay of intracellular free and macromolecular-bound metabolites of 5-fluorodeoxyuridine and 5-fluorouracil, Cancer Res., 39, 3397
Winnick, 1963, Some metabolic and enzymic experiments with α-fluoro-β-alanine, Biochim. Biophys. Acta, 69, 48, 10.1016/0006-3002(63)91224-1
Wolf, 1987, Fluorine-19 NMR spectroscopic studies of the metabolism of 5-fluorouracil in the liver of patients undergoing chemotherapy, Magn. Reson. Imaging, 5, 165, 10.1016/0730-725X(87)90016-6
Young, 1982, Metabolic and distribution studies with radiolabeled 5-fluorouracil, Nucl. Med., 21, 1